Skip to content

Effect of lignocaine to decrease pain in patients undergoing RFA liver

To analyse the effect of topicalization of Glissonian capsule with 2% Lignocaine on anaesthetic drug doses for Monitored anaesthesia care in Percutaneous radiofrequency ablation of Liver.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048741
Enrollment
10
Registered
2023-01-04
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C228- Malignant neoplasm of liver, primary, unspecified as to type

Interventions

Intervention1: 2% lignocaine: upto 5ml/kg of 2% lignocaine will be infiltrated at liver capsule over the subcapsular lesion. Duration of procedure 20 min Control Intervention1: No intervention at live

Sponsors

Rajiv Gandhi Cancer Institute and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA Grade(I-III) 2.All patients with Subcapsular Liver lesion posted for RFA/microwave ablation

Exclusion criteria

Exclusion criteria: 1.Patients with history of M.I, Arrythmia or any other cardiac morbidity. 2.Difficult airway 3.Deranged liver function test and coagulation profile 4.Chronic alcoholic 5.History of any cognitive or psychiatric illness 6.Patients on medication for chronic pain 7.Allergy to Lignocaine 8.Patient on ventilator, poor GCS

Design outcomes

Primary

MeasureTime frame
To achieve a visual analogue pain score of 3 during the procedure.Timepoint: 0 min Baseline preprocedure 2 min after start of procedure 6 min after start of procedure 8 min after start of procedure 10 min after start of procedure

Secondary

MeasureTime frame
Arterial oxygen saturationTimepoint: 0 min Baseline preprocedure 2 min after start of procedure 6 min after start of procedure 8 min after start of procedure 10 min after start of procedure 0 hour immediate post procedure 6 hour post procedure 10 hour post procedure 14 hour post procedure;Heart RateTimepoint: 0 min Baseline preprocedure 2 min after start of procedure 6 min after start of procedure 8 min after start of procedure 10 min after start of procedure 0 hour immediate post procedure 6 hour post procedure 10 hour post procedure 14 hour post procedure ;Mean arterial pressureTimepoint: 0 min Baseline preprocedure 2 min after start of procedure 6 min after start of procedure 8 min after start of procedure 10 min after start of procedure 0 hour immediate post procedure 6 hour post procedure 10 hour post procedure 14 hour post procedure;Respiratory rateTimepoint: 0 min Baseline preprocedure 2 min after start of procedure 6 min after start of procedure 8 min after start of procedure 10 min after start of procedure 0 hour immediate post procedure 6 hour post procedure 10 hour post procedure 14 hour post procedure;To compare the Observer assessment of alertness scoreTimepoint: 0 min Baseline preprocedure 2 min after start of procedure 6 min after start of procedure 8 min after start of procedure 10 min after start of procedure 0 hour immediate post procedure 6 hour post procedure 10 hour post procedure 14 hour post procedure;To compare the patient, anaesthetist and Interventional radiologist satisfaction score.Timepoint: Post procedure;To compare visual analogue score in post procedure periodTimepoint: 0 hour immediate post procedure 6 hour post procedure 10 hour post procedure 14 hour post procedure

Countries

India

Contacts

Public ContactDr Nitesh goel

Rajiv Gandhi Cancer Institute and Research Centre

drniteshgoel@gmail.com9717773292

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026